HomeAI · summaries
Storia in 3 fonti
Employer Co-Pays For GLP-1 Weight Loss Drugs To Rise If They’re Covered
GLP-1 weight loss drugs like Ozempic, Zepbound and Wegovy are the biggest contributor to rising prescription spending. And that will trigger co-payments to rise.
Confronto fonti
3 prospettive sulla stessa storiaTimeline cronologica
- ·
scmp.com
How GLP-1s are more than just weight-loss wonders – but not without risk
Research suggests GLP-1s like Ozempic may help with more than just weight loss and type 2 diabetes, but experts warn of risks from abuse.
- ·
forbes.com
Employer Co-Pays For GLP-1 Weight Loss Drugs To Rise If They’re Covered
GLP-1 weight loss drugs like Ozempic, Zepbound and Wegovy are the biggest contributor to rising prescription spending. And that will trigger co-payments to rise.
- ·
gizmodo.com
Ozempic Is Finally Turning the Tide Against Obesity, New Data Shows
As the rate of GLP-1 prescriptions in the U.S. has risen, the obesity rate has dropped.